Ulcerative Colitis Clinical Trials

Showing 8681-8700 of 9,572 trials

A Comparison of the Effects of Tiotropium Inhalation qd and Salmeterol Inhalation Bid on Arterial Blood Gases.

NCT00274534

To evaluate changes in PaO2 following inhalation of Tiotropium by HandiHaler compared to Salmeterol MDI in patients with moderate to severe COPD.

Pulmonary Disease, Chronic Obstructive

Boehringer Ingelheim36 participantsStarted Dec 2000

Hines, Illinois, United States • Richmond, Virginia, United States

COMPLETEDPhase 3

Comparison of Tiotropium and Ipratropium in a Double-Blind, Double-dummy, Efficacy and Safety Study in Adults With COPD

NCT00274040

Comparison of 18 mcg of Tiotropium Inhalation Capsules and ipratropiumMetered Dose Inhaler (2 puffs of 20 mcg, four times daily) in a Double-Blind, Double-dummy, Efficacy and Safety Study in Adults with Chronic Obstructive Pulmonary Disease (COPD). The objective of this study is to compare the bronchodilator efficacy and safety of tiotropium inhalation capsules (18 mcg once daily) and ipratropium MDI (2 puffs of 20 mcg q.i.d.) in patients with chronic obstructive pulmonary disease (COPD).

Pulmonary Disease, Chronic Obstructive

Boehringer Ingelheim141 participantsStarted Jul 2002

Daejeon, South Korea • Jeonju, South Korea • Kwangju, South Korea +15 more locations

A Comparison of the Effects of Tiotropium Inhalation qd and Salmeterol Inhalation Bid on Arterial Blood Gases.

Comparison of Tiotropium and Ipratropium in a Double-Blind, Double-dummy, Efficacy and Safety Study in Adults With COPD

Related Searches

Ocular Hypertension Treatment Study (OHTS)

Spiriva (Tiotropium Bromide) Assessment of FEV1 - (SAFE-Portugal).

12 Week Comparison of 5 Mcg and 10 Mcg of Tiotropium / Respimat, Placebo and Ipratropium MDI in COPD

Mechanisms of Dyspnea Relief During Exercise in COPD Patients Following Treatment With Tiotropium (Spiriva)

Effects of a 9-months Treatment of SPIRIVA on Health Related Quality of Life in Patients With COPD

Efficacy and Safety Comparison of Tiotropium Inhalation Solution (Respimat Inhaler) and Spiriva HandiHaler in Chronic Obstructive Pulmonary Disease (COPD)

Tiotropium (18 Mcg) Once Daily Via the HandiHaler® in Patients With Chronic Obstructive Pulmonary Disease (COPD)

12 Week Comparison of 5 Mcg and 10 Mcg of Tiotropium / Respimat, Placebo and Ipratropium MDI in COPD

Medication Strategies for Treating Aggressive Behavior in Youth With Attention Deficit Hyperactivity Disorder

SCOPE-Study: Salzburg Chronic Obstructive Pulmonary Disease- Exercise and Oxygen Study

Spontaneous Atrioventricular Conduction Preservation

Efficacy of Long Pulsed 1064nm Laser for Facial Skin Tightening

Effects of Tobacco Smoke Exposure on Epigenetic Signatures and Immunotoxicological Reactions

High Dose Trial in COPD

Effect of Modality on Discharge Instruction in Patients Receiving Outpatient Antibiotic Prescriptions From the Emergency Department

Montelukast for Children With Chronic Otitis Media With Effusion (COME): A Double-blind, Placebo-controlled Study

Tolerability of Pentasa Sachet in Patients With Ulcerative Colitis

Safety and Efficacy of AGN 210669 Ophthalmic Solution in Patients With Ocular Hypertension or Primary Open-Angle Glaucoma